{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:35:59Z","timestamp":1776990959169,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"DOI":"10.1186\/s12894-026-02113-5","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T04:46:34Z","timestamp":1773722794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is MRI\/US-guided fusion biopsy ready to replace systematic biopsy in detecting clinically significant prostate carcinoma? \u2013 a retrospective study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0697-2538","authenticated-orcid":false,"given":"Alexandra","family":"\u00d6kr\u00f6si","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander Peltzer","family":"Svarer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor","family":"Rosta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Wambacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gertraud","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"2113_CR1","volume-title":"Global Cancer Observatory: Cancer Today","author":"J Ferlay","year":"2024","unstructured":"Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer; 2024."},{"issue":"6","key":"2113_CR2","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/apm.12533","volume":"124","author":"L Egevad","year":"2016","unstructured":"Egevad L, Delahunt B, Srigley JR, Samaratunga H. International Society of Urological Pathology (ISUP) grading of prostate cancer - An ISUP consensus on contemporary grading. APMIS. 2016;124(6):433\u20135.","journal-title":"APMIS"},{"issue":"4","key":"2113_CR3","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/iju.13294","volume":"24","author":"AR Alberts","year":"2017","unstructured":"Alberts AR, Bokhorst LP, Kweldam CF, Schoots IG, van der Kwast TH, van Leenders GJ, et al. Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam. Int J Urol. 2017;24(4):281\u20136.","journal-title":"Int J Urol"},{"issue":"10","key":"2113_CR4","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/bjc.2014.192","volume":"110","author":"GL Shaw","year":"2014","unstructured":"Shaw GL, Thomas BC, Dawson SN, Srivastava G, Vowler SL, Gnanapragasam VJ, et al. Identification of pathologically insignificant prostate cancer is not accurate in unscreened men. Br J Cancer. 2014;110(10):2405\u201311.","journal-title":"Br J Cancer"},{"issue":"8","key":"2113_CR5","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/nrurol.2013.112","volume":"10","author":"TH Van der Kwast","year":"2013","unstructured":"Van der Kwast TH, Roobol MJ. Defining the threshold for significant versus insignificant prostate cancer. Nat Rev Urol. 2013;10(8):473\u201382.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"2113_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s00120-022-01806-7","volume":"61","author":"J Herrmann","year":"2022","unstructured":"Herrmann J, Kaufmann S, Zhang C, Rausch S, Bedke J, Stenzl A, et al. [Multiparametric MRI of the prostate]. Urologe A. 2022;61(4):428\u201340.","journal-title":"Urologe A"},{"key":"2113_CR7","doi-asserted-by":"crossref","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, et al. Eur Urol. 2019;76(3):340\u201351. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.","DOI":"10.1016\/j.eururo.2019.02.033"},{"issue":"3","key":"2113_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.clon.2020.01.001","volume":"32","author":"JO Tam","year":"2020","unstructured":"Tam JO, Ahmed HU. Targeted and Systematic Biopsy for the Diagnosis and Management of Prostate Cancer - A Case for Lesion Targeted-Only Biopsies. Clin Oncol (R Coll Radiol). 2020;32(3):136\u201343.","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2113_CR9","doi-asserted-by":"crossref","unstructured":"Kania E, Janica M, Hrehoruk G, Kurowski P, Ostasiewicz A, Samocik P et al. Enhancing Prostate Cancer Diagnosis: A Comparative Analysis of Combined Fusion and Systematic Biopsy Methods\u2014A Single-Center Study. J Clin Med. 2025;14(8):2822.","DOI":"10.3390\/jcm14082822"},{"issue":"4","key":"2113_CR10","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1097\/JU.0000000000002802","volume":"208","author":"F Zattoni","year":"2022","unstructured":"Zattoni F, Marra G, Kasivisvanathan V, Grummet J, Nandurkar R, Ploussard G, et al. The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study. J Urol. 2022;208(4):830\u20137.","journal-title":"J Urol"},{"issue":"4","key":"2113_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4103\/aja20241","volume":"26","author":"JX Liu","year":"2024","unstructured":"Liu JX, Wang ZY, Niu SX, Sai XY, Zhang X, Zhang XP, et al. Transrectal versus transperineal prostate biopsy for cancer detection in patients with gray-zone prostate-specific antigen: a multicenter, real-world study. Asian J Androl. 2024;26(4):377\u201381.","journal-title":"Asian J Androl"},{"key":"2113_CR12","doi-asserted-by":"crossref","unstructured":"Hoeh B, Wenzel M, Humke C, Cano Garcia C, Siech C, Schneider M et al. Transition from Transrectal to Transperineal MRI-Fusion Prostate Biopsy Does Not Comprise Detection Rates of Clinically Significant Prostate Cancer at a Tertiary Care Center. Diagnostics. 2024;14(11):1184.","DOI":"10.3390\/diagnostics14111184"},{"issue":"10","key":"2113_CR13","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1910038","volume":"382","author":"M Ahdoot","year":"2020","unstructured":"Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, et al. MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis. N Engl J Med. 2020;382(10):917\u201328.","journal-title":"N Engl J Med"},{"key":"2113_CR14","doi-asserted-by":"publisher","first-page":"110432","DOI":"10.1016\/j.ejrad.2022.110432","volume":"154","author":"J Dorfinger","year":"2022","unstructured":"Dorfinger J, Ponholzer A, Stolzlechner M, Lenart S, Baltzer P, Toepker M. MRI\/ultrasound fusion biopsy of the prostate compared to systematic prostate biopsy \u2013 Effectiveness and accuracy of a combined approach in daily clinical practice. Eur J Radiol. 2022;154:110432.","journal-title":"Eur J Radiol"},{"issue":"2","key":"2113_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00345-018-2399-z","volume":"37","author":"G Ploussard","year":"2019","unstructured":"Ploussard G, Borgmann H, Briganti A, de Visschere P, F\u00fctterer JJ, Gandaglia G, et al. Positive pre-biopsy MRI: are systematic biopsies still useful in addition to targeted biopsies? World J Urol. 2019;37(2):243\u201351.","journal-title":"World J Urol"},{"issue":"19","key":"2113_CR16","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M, Panebianco V, Mynderse LA, Vaarala MH, et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018;378(19):1767\u201377.","journal-title":"N Engl J Med"},{"issue":"3","key":"2113_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/pros.24286","volume":"82","author":"B Kaufmann","year":"2022","unstructured":"Kaufmann B, Saba K, Schmidli TS, Stutz S, Bissig L, Britschgi AJ, et al. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy. Prostate. 2022;82(3):388\u201396.","journal-title":"Prostate"},{"issue":"4","key":"2113_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.2014.17942","volume":"313","author":"MM Siddiqui","year":"2015","unstructured":"Siddiqui MM, Rais-Bahrami S, Turkbey B, George AK, Rothwax J, Shakir N, et al. Comparison of MR\/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. JAMA. 2015;313(4):390\u20137.","journal-title":"JAMA"},{"issue":"2","key":"2113_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.juro.2018.02.067","volume":"200","author":"A Mortezavi","year":"2018","unstructured":"Mortezavi A, M\u00e4rzendorfer O, Donati OF, Rizzi G, Rupp NJ, Wettstein MS, et al. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer. J Urol. 2018;200(2):309\u201318.","journal-title":"J Urol"},{"key":"2113_CR20","doi-asserted-by":"crossref","unstructured":"Dagnino F, Avolio PP, Fasulo V, Piccolini A, Aljoulani M, Moretto S et al. Clinically significant prostate cancer detection rate in biopsy-na\u00efve patients with mpMRI and microultrasound topographically discordant lesions: A single-center retrospective analysis. Urol Oncol. 2024;42(12):447.e11\u2013.e16.","DOI":"10.1016\/j.urolonc.2024.06.021"},{"issue":"61","key":"2113_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/PLFG4210","volume":"28","author":"A Llewellyn","year":"2024","unstructured":"Llewellyn A, Phung TH, O Soares M, Shepherd L, Glynn D, Harden M, et al. MRI software and cognitive fusion biopsies in people with suspected prostate cancer: a systematic review, network meta-analysis and cost-effectiveness analysis. Health Technol Assess. 2024;28(61):1\u2013310.","journal-title":"Health Technol Assess"},{"issue":"3","key":"2113_CR22","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41391-022-00620-8","volume":"26","author":"JP Noujeim","year":"2023","unstructured":"Noujeim JP, Belahsen Y, Lefebvre Y, Lemort M, Deforche M, Sirtaine N, et al. Optimizing multiparametric magnetic resonance imaging-targeted biopsy and detection of clinically significant prostate cancer: the role of perilesional sampling. Prostate Cancer Prostatic Dis. 2023;26(3):575\u201380.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2113_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.euros.2022.07.006","volume":"43","author":"MJ Hagens","year":"2022","unstructured":"Hagens MJ, Noordzij MA, Mazel JW, Jager A, Boellaard TN, Tielbeek JAW, et al. An Magnetic Resonance Imaging-directed Targeted-plus-perilesional Biopsy Approach for Prostate Cancer Diagnosis: Less Is More. Eur Urol Open Sci. 2022;43:68\u201373.","journal-title":"Eur Urol Open Sci"},{"issue":"2","key":"2113_CR24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00345-018-02622-5","volume":"37","author":"G Marra","year":"2019","unstructured":"Marra G, Ploussard G, Futterer J, Valerio M, EAU-YAU Prostate Cancer Working Party. Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach? World J Urol. 2019;37(2):277\u201387.","journal-title":"World J Urol"},{"issue":"5","key":"2113_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.euo.2020.12.004","volume":"4","author":"E Mazzone","year":"2021","unstructured":"Mazzone E, Stabile A, Pellegrino F, Basile G, Cignoli D, Cirulli GO, et al. Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Oncol. 2021;4(5):697\u2013713.","journal-title":"Eur Urol Oncol"},{"issue":"3","key":"2113_CR26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41391-020-0205-7","volume":"23","author":"Y Ber","year":"2020","unstructured":"Ber Y, Segal N, Tamir S, Benjaminov O, Yakimov M, Sela S, et al. A noninferiority within-person study comparing the accuracy of transperineal to transrectal MRI-US fusion biopsy for prostate-cancer detection. Prostate Cancer Prostatic Dis. 2020;23(3):449\u201356.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"2","key":"2113_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5152\/tud.2022.21248","volume":"48","author":"A El-Achkar","year":"2022","unstructured":"El-Achkar A, Abou Heidar N, Labban M, Al-Moussawy M, Moukaddem H, Nasr R, et al. MRI\/US fusion transperineal versus transrectral biopsy of prostate cancer: Outcomes and complication rates, a tertiary medical center experience in the Middle East. Turk J Urol. 2022;48(2):98\u2013105.","journal-title":"Turk J Urol"},{"issue":"1","key":"2113_CR28","doi-asserted-by":"publisher","first-page":"13457","DOI":"10.1038\/s41598-023-40371-7","volume":"13","author":"M Kaneko","year":"2023","unstructured":"Kaneko M, Medina LG, Lenon MSL, Hemal S, Sayegh AS, Jadvar DS, et al. Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: a pair-matched comparison. Sci Rep. 2023;13(1):13457.","journal-title":"Sci Rep"},{"issue":"6","key":"2113_CR29","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.euo.2020.12.012","volume":"4","author":"BP Rai","year":"2021","unstructured":"Rai BP, Mayerhofer C, Somani BK, Kallidonis P, Nagele U, Tokas T. Magnetic Resonance Imaging\/Ultrasound Fusion-guided Transperineal Versus Magnetic Resonance Imaging\/Ultrasound Fusion-guided Transrectal Prostate Biopsy-A Systematic Review. Eur Urol Oncol. 2021;4(6):904\u201313.","journal-title":"Eur Urol Oncol"},{"key":"2113_CR30","doi-asserted-by":"crossref","unstructured":"Paesano N, Catal\u00e1 V, Tcholakian L, Trilla E, Morote J. A Systematic Review of the Current Status of Magnetic Resonance-Ultrasound Images Fusion Software Platforms for Transperineal Prostate Biopsies. Cancers (Basel). 2023;15(13):3329 .","DOI":"10.3390\/cancers15133329"},{"issue":"1","key":"2113_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12957-019-1573-0","volume":"17","author":"J Xiang","year":"2019","unstructured":"Xiang J, Yan H, Li J, Wang X, Chen H, Zheng X. Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis. World J Surg Oncol. 2019;17(1):31.","journal-title":"World J Surg Oncol"},{"issue":"8","key":"2113_CR32","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.urolonc.2020.04.005","volume":"38","author":"LM Loy","year":"2020","unstructured":"Loy LM, Lim GH, Leow JJ, Lee CH, Tan TW, Tan CH. A systematic review and meta-analysis of magnetic resonance imaging and ultrasound guided fusion biopsy of prostate for cancer detection-Comparing transrectal with transperineal approaches. Urol Oncol. 2020;38(8):650\u201360.","journal-title":"Urol Oncol"},{"key":"2113_CR33","unstructured":"EAU Guidelines. Edn. presented at the EAU Annual Congress Paris 2024. ISBN 978-94-92671-23-3."},{"issue":"2","key":"2113_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/bju.15277","volume":"127","author":"IG Schoots","year":"2021","unstructured":"Schoots IG, Padhani AR. Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation. BJU Int. 2021;127(2):175\u20138.","journal-title":"BJU Int"},{"key":"2113_CR35","doi-asserted-by":"crossref","unstructured":"Stevens E, Truong M, Bullen JA, Ward RD, Purysko AS, Klein EA. Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer. Urologic Oncology: Seminars and Original Investigations. 2020;38(11):846.e9-846.e16.","DOI":"10.1016\/j.urolonc.2020.05.024"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-026-02113-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02113-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-026-02113-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T23:47:59Z","timestamp":1776988079000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12894-026-02113-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2113"],"URL":"https:\/\/doi.org\/10.1186\/s12894-026-02113-5","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"2 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the declaration of Helsinki and approved by the Institutional Ethics Committee of The Human Investigation Committee (IRB) of University Karl Landsteiner (protocol code 1083\/2024,18.12.2024) for studies involving humans.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The requirement for informed consent was waived due to the retrospective nature of the study and the use of anonymized data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}